Author:
Verbiest Annelies,Renders Inne,Caruso Stefano,Couchy Gabrielle,Job Sylvie,Laenen Annouschka,Verkarre Virginie,Rioux-Leclercq Nathalie,Schöffski Patrick,Vano Yann,Elaidi Reza-Thierry,Lerut Evelyne,Albersen Maarten,Oudard Stéphane,Fridman Wolf-Hervé,Sautès-Fridman Catherine,Albigès Laurence,Wozniak Agnieszka,Zucman-Rossi Jessica,Beuselinck Benoit
Reference19 articles.
1. Renal cell carcinoma;Hsieh;Nat Rev Dis Primers,2017
2. Updated European Association of Urology Guidelines recommendations for the treatment of first-line metastatic clear cell renal cancer;Powles;Eur Urol,2018
3. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N Engl J Med,2019
4. Molecular correlates differentiate response to atezolizumab (atezo)+ bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC);Rini;ESMO Annu Congress,2018
5. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Rini;N Engl J Med,2019
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献